Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF DECEMBER 05, 2007 FBO #2200
MODIFICATION

A -- Statistical and Data Coordinating Center (SDCC) for Clinical Research in Infectious Diseases

Notice Date
12/22/2006
 
Notice Type
Modification
 
NAICS
541710 — Research and Development in the Physical, Engineering, and Life Sciences (NAICS 2002)
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Office of Acquisitions 6700 B Rockledge Room 3214 MSC7612, Bethesda, MD, 20892-7612, UNITED STATES
 
ZIP Code
20892-7612
 
Solicitation Number
RFP-NIH-NIAID-DMID-08-04
 
Response Due
5/14/2007
 
Point of Contact
Deborah Baca, Contract Specialist, Phone 301-443-4490, Fax null
 
E-Mail Address
dbaca@mail.nih.gov
 
Small Business Set-Aside
Total Small Business
 
Description
NOTICE HAS BEEN REVISED TO CHANGE ANTICIPATED POSTING DATE OF RFP FROM DECEMBER 21, 2006 TO JANUARY 2, 2007. The Office of Clinical Research Affairs (OCRA) of the Division of Microbiology and Infectious Diseases (DMID) of the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Department of Health and Human Services (DHHS), intends to recompete a requirement for capabilities and facilities to establish and manage a Statistical and Data Coordinating Center (SDCC) to support NIAID sponsored clinical research programs in infectious diseases. This is a 100% SMALL BUSINESS SET-ASIDE, NAICS 541710 with a size standard of 500 employees. It is anticipated that a single cost reimbursement completion type contract will be awarded for a 7-year period with performance beginning on or about March 3, 2008, with an anticipated total effort of approximately 40.75 FTEs. The NIAID, DMID supports extramural research to understand and ultimately prevent and/or treat diseases caused by virtually all infectious agents other than HIV that threaten millions of lives every year. This includes basic and applied research to develop and evaluate therapeutics, vaccines and diagnostics which are funded through a variety of research grants and contracts. DMID is also responsible for advancing clinical research and conducting clinical trials to evaluate the safety and efficacy of vaccines and therapeutic agents against potential bioterrorist pathogens and new and re-emerging infectious diseases of public health importance, such as avian influenza and SARS. The primary goal of this seven-year effort is to facilitate the evaluation of new vaccines, other prophylactic strategies, and therapeutic agents for infectious diseases of priority to the Division. Support will be provided for single- and multi-center Phase 1, 2, 3 and 4 clinical trials of vaccines, other biologics, therapeutic agents aimed at bacterial, viral and parasitic diseases that occur in people of all ages at DMID-sponsored Vaccine and Treatment Evaluation Units (VTEUs) and other clinical research centers. The contractor's primary goal will be to coordinate clinical trials with respect to elements of study planning and logistics, training and communications, data collection, management and analysis and related support activities. This will typically involve a multi-center effort and a collaborative relationship with clinical investigators, other supporting contractors and DMID staff. The support services to be provided by the contractor under this contract include the following: 1) computerized systems for the collection, management, storage, security, reporting and quality control of study data including systems to accommodate on-line subject enrollment and randomization; 2) statistical expertise in study design and analysis of trials; 3) assistance with preparation of study-related materials such as Manuals of Operations, case report forms and/or source documents and tracking logs; 4) development and maintenance of protocol web sites to share information and study materials with study sites and to provide DMID with real-time study information, such as overall and site-specific accrual, demographics, adverse events, queries, and deviations; 5) development and maintenance of an electronic inventory system to identify and track clinical study specimens; 6) providing training to clinical site staff to access the data system, perform remote data entry and enter clinical specimens into the electronic inventory system; 7) assessing capabilities and providing assistance to sites that intend to perform their own data collection, management, security and quality control; and 8) serving as a repository to store data from completed studies. NOTE: THIS NOTICE MAY HAVE POSTED ON FEDBIZOPPS ON THE DATE INDICATED IN THE NOTICE ITSELF (22-DEC-2006). IT ACTUALLY APPEARED OR REAPPEARED ON THE FEDBIZOPPS SYSTEM ON 03-DEC-2007, BUT REAPPEARED IN THE FTP FEED FOR THIS POSTING DATE. PLEASE CONTACT fbo.support@gsa.gov REGARDING THIS ISSUE.
 
Web Link
Link to FedBizOpps document.
(http://www.fbo.gov/spg/HHS/NIH/NIAID/RFP-NIH-NIAID-DMID-08-04/listing.html)
 
Record
SN01462525-F 20071205/071203231015 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.